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ORIGINAL ARTICLE
Rhubarb extract partially improves mucosal integrity in 
chemotherapy-induced intestinal mucositis
Basic Study




To investigate the effects of orally gavaged aqueous 
rhubarb extract (RE) on 5-fluorouracil (5-FU)-induced 
intestinal mucositis in rats. 
METHODS
Female Dark Agouti rats (n  = 8/group) were gavaged 
daily (1 mL) with water, high-dose RE (HDR; 200 mg/
kg) or low-dose RE (LDR; 20mg/kg) for eight days. 
Intestinal mucositis was induced (day 5) with 5-FU 
(150 mg/kg) via  intraperitoneal injection. Intestinal 
tissue samples were collected for myeloperoxidase 
(MPO) activity and histological examination. Xenopus 
oocytes expressing aquaporin 4 water channels were 
prepared to examine the effect of aqueous RE on cell 
volume, indicating a potential mechanism responsible 
for modulating net fluid absorption and secretion in 
the gastrointestinal tract. Statistical significance was 
assumed at P  < 0.05 by one-way ANOVA. 
RESULTS
Bodyweight was s ignif icant ly reduced in rats 
administered 5-FU compared to healthy controls (P  < 
0.01). Rats administered 5-FU significantly increased 
intestinal MPO levels (≥ 307%; P  < 0.001), compared 
to healthy controls. However, LDR attenuated this 
effect in 5-FU treated rats, significantly decreasing 
ileal MPO activity (by 45%; P  < 0.05), as compared 
to 5-FU controls. 5-FU significantly reduced intestinal 
mucosal thickness (by ≥ 29% P  < 0.001) as compared 
to healthy controls. LDR significantly increased ileal 
mucosal thickness in 5-FU treated rats (19%; P  < 0.05) 
relative to 5-FU controls. In xenopus oocytes expressing 
AQP4 water channels, RE selectively blocked water 
influx into the cell, induced by a decrease in external 
osmotic pressure. As water efflux was unaltered by 
the presence of extracellular RE, the directional flow of 
water across the epithelial barrier, in the presence of 
extracellular RE, indicated that RE may alleviate water 
loss across the epithelial barrier and promote intestinal 
health in chemotherapy-induced intestinal mucositis.
CONCLUSION
In summary, low dose RE improves selected parameters 
of mucosal integrity and reduces ileal inflammation, 
manifesting from 5-FU-induced intestinal mucositis. 
Key words: Fluorouracil; Inflammation; Mucositis; Rats; 
Rheum
© The Author(s) 2016. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Aqueous rhubarb extract partially improved 
selected parameters of 5-fluorouracil (5-FU)-induced 
intestinal mucositis in rats. Exposure to 5-FU decreased 
bodyweight, yet high-dose rhubarb extract (RE) and low-
dose RE (LDR) showed no changes. Myeloperoxidase 
activity was significantly decreased in rats treated with 
LDR and 5-FU when compared to the intestinal mucositis 
control group. Ileal mucosal thickness was significantly 
improved (19%) in animals with intestinal mucositis 
and treated with LDR. In xenopus oocytes expressing 
AQP4 water channels, RE blocked swelling induced by a 
decrease in external osmotic pressure which indicated 
that water influx across the epithelial barrier was 
selectively blocked by RE.
Bajic JE, Eden GL, Lampton LS, Cheah KY, Lymn KA, Pei 
JV, Yool AJ, Howarth GS. Rhubarb extract partially improves 
mucosal integrity in chemotherapy-induced intestinal mucositis. 




Traditional herbal medicines have been used for 
centuries in the maintenance and improvement of 
health or the treatment of illnesses. Globally, ancient 
herbal remedies have been created based on theories, 
beliefs and experiences representing various cultures 
at different times throughout history[1]. Consequently, 
traditional herbal medicines are being investigated 
increasingly for their potential to treat and reduce 
the symptoms of a wide variety of diseases and dis­
orders, specifically cancer and its treatment­related 
side­effects. Many cancer patients seek alternative 
medicines that will complement their standard­care 
treatments with the hope that they will improve 
symptoms associated with either the cancer or their 
anti­cancer treatments[2]. 
Cancer is a life­threatening illness affecting millions 
of individuals world­wide. In westernized countries 
approximately 50% of the population will develop 
cancer before the age of 85[3]. Chemotherapy forms 
one of the most common strategies for cancer 
treatment. Cytotoxic chemotherapy drugs, such as 
5-fluorouracil (5-FU), act by inhibiting DNA synthesis 
of not only malignant cells, but also rapidly dividing 
cells lining the intestinal mucosa[4]. An increase in cell 
apoptosis stimulates the production of reactive oxygen 
species (ROS) and pro-inflammatory cytokines such 
as tumour necrosis factor­α (TNF-α), interleukin-1β 
(IL-1β) and IL-4 resulting in further tissue and blood 
vessel damage[5,6]. This cascade of events results 
in a range of debilitating clinical side­effects, from 
nausea and vomiting to inflammation and ulceration 
of the gastrointestinal tract; and sepsis may occur 
if untreated[7,8]. These painful and life­threatening 
side­effects collectively form a disorder known as 
intestinal mucositis which affects approximately 60% 
of patients undergoing chemotherapy[9]. Current 
therapies for intestinal mucositis seek to reduce the 
severity of symptoms rather than acting as a curative 
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or preventative measure[10,11]. Thus, treatments are 
required with the potential to eliminate or reduce the 
adverse side­effects of cancer chemotherapy.
Recently, in experimental systems, plant extracts 
such as grape seed extract (GSE) and Iberogast® have 
been investigated as potential treatments for intestinal 
mucositis on the basis of their anti­inflammatory and 
antioxidant constituents[12­14]. Indeed, plant­sourced 
molecules and compounds are commonly percei­
ved to be safer therapeutics compared to synthetic 
compounds[15]. There are limited studies on the phar­
macology of herbal medicines, yet such extracts may 
offer protection against intestinal mucositis in an 
experimental setting. The scientific study of further 
plant­based extracts is therefore warranted. 
Rhubarb, Rheum spp., is a herbaceous perennial 
plant with a long, fleshy stalk, commonly used for 
cooking and medicine. Dried rhubarb rhizomes were 
traditionally used in Chinese medicine as a natural 
remedy for gastrointestinal complications including 
diarrhoea, constipation and inflammation[16]. The 
pharmacological effects have been attributed to the 
stalk of the plant[17,18]. Two main active constituents 
(ethanol-soluble and water soluble) have been 
classified in rhubarb stalks. Anthraquinones form the 
main ethanol­soluble active constituent of rhubarb 
stalks[14]. These constituents have exhibited a diar­
rhoeal effect in mice providing a possible purgative 
mechanism of action[18]. In contrast, the aqueous 
extract of rhubarb has recently demonstrated anti­
diarrhoeal properties, believed to be mediated by 
tannins through regulation of intestinal water secre­
tion and absorption[18]. Importantly, chemotherapy 
recipients experiencing intestinal mucositis have 
altered membrane integrity and impaired water 
absorption and secretion[7,19].
Aquaporins (AQPs) are integral membrane proteins 
responsible for the regulation of water transport 
across a membrane via an osmotic gradient[20,21]. 
Aquaporin channels are tetramers with a water pore 
located in each subunit of the channel (Figure 1A). 
Water molecules move in single file through aquaporin 
pores, down osmotic and hydrostatic gradients. As 
one molecule enters via the extracellular region of 
the channel, another molecule is displaced into the 
cytoplasm and vice versa[22]. Currently, 13 mammalian 
AQPs have been identified (AQP 0-12). AQPs are 
abundant in tissues reliant on high water permeability 
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Figure 1  Directional blockade of water flux through an aquaporin-4 channel by reconstituted aqueous rhubarb extract. A: Diagram of a water channel 
illustrating the intra-subunit water pores in each subunit of the tetramer; B: Illustration of the volume changes induced by osmotic gradients in mammalian AQP4-
expressing Xenopus oocytes; C: Dose-dependent blockade of swelling but not shrinking responses by rhubarb extract (RE) in AQP4-expressing oocytes; D: Diagram 
of the hypothesized effect of blockade by extracellular RE at AQP4 channels present in the basolateral side of intestinal barrier epithelial cells, predicted to result in 
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were obtained for every 500 g of fresh rhubarb. 
Based on fractionation of the extract, the active agent 
appears to be a water­soluble ethanol­insoluble 
glycopeptide. Lectin array profiling has indicated that 
mannose and N-acetylglucosamine are predominant 
components of the carbohydrate structure. The precise 
chemical structure and possible presence of more 
than one isoform with biological activity remains to be 
determined.
Animal trial, metabolism data and disease Activity index
Six week old female Dark Agouti rats (n = 32; 
110-150 g) were sourced from the Animal Resources 
Centre (Western Australia) and Laboratory Animal 
Services (The University of Adelaide, South Australia). 
All animal experimentation was approved by the 
Animal Ethics Committee of the University of Adelaide 
(S-2010-111). The animal protocol described in this 
study was designed to minimise pain or discomfort 
to the animals and complied with the National Health 
and Medical Research Council Code of Practice for 
Animal Care in Research and Teaching. Prior to the 
experimentation period, rats were individually housed 
in Tecniplast™ (PA, United States) metabolism cages 
for 48 hours to acclimatise. Rats received ad libitum 
water and 18% Casein diet[30] and were exposed to 
a 12 h light­dark cycle in a temperature controlled 
room (22 ℃). After the acclimatisation phase, rats 
were randomly allocated to four treatment groups 
(n= 8/group): Water + Saline, Water + 5-FU, Low-
Dose Rhubarb (LDR; 20 mg/kg BW) + 5-FU and 
High-Dose Rhubarb (HDR; 200 mg/kg BW) + 5-FU. 
Water, HDR and LDR (1 mL) were administered daily 
via orogastric gavage on days 0 to 7. LDR dose for 
gavage was based on the estimated dose required to 
block aquaporin water channel activity in the oocyte 
expression system, and the dose HDR was selected as 
a 10 fold higher concentration for comparison.
Daily recordings of body weight, feed and water 
intake and faecal and urine output were conducted. 
Faecal pellets were collected daily, weighed and placed 
in a drying oven at 70 ℃ for 72 h. The percentage 
weight loss was used as an indication of moisture 
content in the faecal samples. On day 5, rats were 
injected with 5-FU (150 mg/kg BW; Hospira Australia 
Pty Ltd, Melbourne, Victoria) to induce intestinal 
mucositis. The single high dose of 5-FU used in the 
current study was determined from previous studies in 
our laboratory[31]. Following 5-FU administration, daily 
disease activity index (DAI) scoring was performed by 
a blinded researcher based on overall condition, weight 
loss and stool consistency. Each parameter was scored 
based on a scale of 0 (normal) to 3 (maximal severity) 
giving a maximum daily total of 9 for severely affected 
rats[32,33]. 
Blood, organ and tissue collection
Rats were humanely euthanized on day 8 via carbon 
dioxide asphyxiation. Day 8 of the experimental period 
to maintain correct function[21,23] and are involved 
in metabolic processes such as kidney, lung, brain 
and gastrointestinal function[24­26]. In the human 
gastrointestinal tract, AQPs 3, 7 and 8 are expressed 
throughout the mucosal epithelia, and AQP1 is present 
in endothelial cells of the vasculature. In early stage 
inflammatory bowel disease, tight junctions and 
transport systems are impaired, leading to a leaky 
epithelium. Clinical human biopsies showed that levels 
of expression of AQPs1 and 3 are reduced in Crohn’s 
Disease and AQPs 7 and 8 are decreased in ulcerative 
colitis, based on quantitative PCR and immunolabelling 
assays[27]. As well, the typical apical localisation of 
AQP8 in bowel was lost, and the appearance of a faint 
basolateral signal suggested intestinal epithelial cell 
polarity was disrupted. 
Aquaporin-4 (AQP 4) is believed to provide the 
principal mechanism for bidirectional water transport 
across the basolateral membrane of small intestinal 
enterocytes[28]. These water channels ensure that 
efficient water absorption and secretion is maintained, 
thus allowing for adequate hydration and optimal 
stool consistency[29]. Liu et al[17] demonstrated that 
the anti­diarrhoeal effect of rhubarb tannins extract 
occurred via the inhibition of AQP 2 and 3 expression 
in vitro and in a mouse model of magnesium sulphate­
induced diarrhoea. In addition, the water­soluble 
polysaccharides of rhubarb have protected the 
gastrointestinal tract against inflammation resulting 
from 2,4,6­trinitrobenzene sulfonic acid­induced 
colitis[17]. The anti-inflammatory mechanism of action 
underlying rhubarb extract (RE) remains unclear; 
however, it is thought that tannins may reduce the 
production of pro-inflammatory cytokines such as IL-4 
and IFN-γ[17]. Consequently, RE was explored for its 
anti-inflammatory potential in intestinal mucositis and 
its potential to influence water transport across the 
intestinal mucosa[17,18].
In the current study, an aqueous fraction of rhubarb 
was investigated for its potential to reduce intestinal 
damage induced by the antimetabolite chemotherapy 
drug, 5-FU in rats. It was hypothesised that RE 
would decrease the severity of intestinal mucositis by 
improving histopathological parameters and potentially 




Rhubarb stems (2.5 kg) were sectioned (1 cm) and 
boiled with absolute ethanol to remove alcohol­soluble 
components. Once cooled, the liquid was discarded 
and the residues were further boiled with water. 
The aqueous rhubarb components were retained 
for dehydration to obtain a concentrated powder[17]. 
Dehydration was conducted by freeze-drying at the 
South Australian Research and Development Institute, 
West Beach, South Australia. Four grams of powder 
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represented 3 d post 5-FU exposure and due to the 
acute nature of 5-FU-induced intestinal mucositis, 
this was determined to be the optimal day when 
histological damage in the intestine was most evident. 
The gastrointestinal tract was removed and emptied, 
then the lengths of each section [duodenum, jejunum, 
jejuno-ileum junction (JI), ileum and colon] were 
recorded and weighed. 
Segments (2 cm and 4 cm) of the small intestine 
tract were collected at approximately 10% (jejunum) 
and 90% (ileum) of the total small intestine length 
for histological and biochemical analysis, respectively. 
Samples for histological analysis were fixed in 10% 
buffered formalin for 24 h and transferred to 70% 
ethanol for preservation. Segments for biochemical 
analysis were weighed and snap­frozen in liquid 
nitrogen prior to storage at ­80 ℃. The remaining 
thoracic and abdominal organs (thymus, lungs, heart, 
spleen, kidneys, liver, stomach and caecum) were 
weighed and discarded. 
Biochemical analysis
Myeloperoxidase (MPO) is an enzyme present in the 
intracellular granules of neutrophils and provides 
a quantitative analysis of acute inflammation. The 
assay was performed with slight modification from 
Beyer et al[34]. Segments of the small intestinal tract 
(jejunum, JI and ileum; 4 cm) were thawed and 
prepared for MPO assay via homogenization in 10 
mmol/L phosphate buffer (pH 6.1). Homogenised 
samples were centrifuged at 13000 rpm for 12 min 
and the supernatant was discarded. The remaining 
pellet was resuspended with 0.5% hexadecyltrimethyl 
ammonium bromide buffer and vortexed prior to a 
final centrifuge (13000 rpm for 2 min). Supernatant 
from each sample (50 µL aliquot) was dispensed into 
a 96-well plate and the MPO reaction was initiated 
with an O-dianisidine dihydrochloride solution (200 
µL/well; 4.2 mg O­dianisidine dihydrochloride, 12.5 
µL hydrogen peroxide (30%) in 2.5 mL potassium 
phosphate buffer (50 mmol/L, pH 6.1) and 22.5 mL 
distilled H2O). A spectrometer (Victor X4 Multilabel 
Reader, Perkin Elmer, Singapore) measured absor-
bance (450 nm) at one minute intervals over a 15 
min period. The change in absorbance was used to 
calculate MPO activity within a tissue sample (MPO 
units/g of intestinal tissue).
Histological analysis
Intestinal samples stored in 70% ethanol were 
embedded with paraffin wax and cross-sectioned at 4 
µm. Histological slides were stained with haematoxylin 
and eosin for qualitative and quantitative analysis. 
Qualitative measurements of 40 villus and crypts 
per intestinal section (jejunum, JI and ileum) were 
performed blinded using Image ProPlus software for 
Windows (version 5.1.1; Media Cybernetics, Silver 
Spring MD, United States) connected to a Nikon 
Eclipse 50i light microscope (Nikon Cooperation, 
Japan) and a ProGres C5 digital camera (Jenoptik, 
Germany). Intestinal sections were also analysed 
quantitatively using disease severity scores based on 
11 criteria described by Howarth et al[32]. Each criterion 
was scored on a scale of 0 (normal) to 3 (severely 
damaged) for five cross-sections of each intestinal 
region. The median score for each criterion was 
calculated and the scores of all criteria were summed 
to give an overall disease severity score; with a score 
of 33 indicating maximal tissue damage[32,33].
Xenopus oocyte preparation
Unfertilized oocytes from Xenopus laevis were prepared 
as described previously[35,36] and maintained in ND96 
saline (96 mmol/L NaCl, 2 mmol/L KCl, 1 mmol/L 
MgCl2, 1.8 mmol/L CaCl2, and 5 mmol/L HEPES, pH 
7.55) supplemented with 100 µg/mL penicillin,100 
U/mL streptomycin, and 10% horse serum. Oocytes 
were injected with 50 nL of water containing 1 ng of 
rat AQP4 wild-type cRNA and were incubated for 2 or 
more days at 16­18 ℃ prior to osmotic swelling and 
shrinking assays in saline without antibiotics or serum. 
Hypotonic saline (50%) was prepared by diluting 
isotonic saline with an equal volume of water, whilst 
200% hypertonic saline was prepared by doubling the 
NaCl concentration of the saline. Volume change rates 
were measured by videomicroscopy at 0.5 frames/s 
over 30 s using NIH ImageJ software (http://rsbweb.
nih.gov/ij/), as described previously[35,36].
Statistical analysis
Statistical analyses were conducted using IBM SPSS 
Statistics version 19 for Windows (SPSS Inc., Chicago, 
IL, United States) and GraphPad Prism 6.02 for 
Windows (GraphPad Software Inc., San Diego, CA, 
United States). Normality tests were performed on all 
data sets to determine parametric and non­parametric 
data. All parametric data (metabolic data, MPO activity 
and villus height/crypt depth measurements) was 
analysed using one-way ANOVA with Tukey post 
hoc test. Non-parametric data (DSS and DAI) was 
analysed using Kruskal-Wallis with Mann Whitney U 
post hoc test. All data were expressed as mean ± SEM 
with the exception of disease severity scores which 
were expressed as medians and range. Values of P < 
0.05 were considered significant. 
RESULTS
Dose-dependent blockade of AQP4 water channel 
activity by extracellular aqueous RE
Cloned rat AQP 4 water channels expressed in Xenopus 
oocytes were analysed quantitatively for osmotically­
driven changes in cell volume in the presence and 
absence of dried reconstituted aqueous RE. Decreased 
external osmotic pressure (50% hypotonic saline) 
induced a volume increase (swelling) that was blocked 
Bajic JE et al . Rhubarb extract partially improves intestinal mucositis
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by RE (Figure 1B and C). In contrast, the volume 
decrease (shrinking) induced by 200% hypertonic 
saline was not significantly altered by RE (Figure 1B 
and C), indicating that the blocking effect of RE was 
directional. In the presence of extracellular RE, water 
influx into the cell mediated by AQP4 was selectively 
blocked, whereas water efflux was not altered, 
providing a potentially useful tool for differentially 
modulating net fluid absorption and secretion in 
the gastrointestinal tract. The current ex vivo study 
predicted that RE would act on basolateral AQP 4 
channels and alleviate water loss across the barrier 
epithelium (Figure 1D), thereby promoting intestinal 
health in the experimental setting of chemotherapy­
induced intestinal mucositis. 
Metabolic data and faecal moisture content 
Low dose rhubarb (LDR) and high dose rhubarb 
(HDR) had no significant effect on metabolic 
parameters (bodyweight, feed and water intake and 
faecal and urine output) when compared to controls 
prior to administration of 5-FU (Table 1). After 5-FU 
administration, feed intake was significantly decreased 
(by 60%; P < 0.001) in comparison to healthy 
controls (Table 2). Furthermore, in 5-FU treated rats 
administered HDR, feed intake was further reduced 
by 55% when compared to 5-FU controls (P < 0.01). 
However, normal feed intake was maintained in 5-FU 
treated rats administered LDR. Although feed intake 
was significantly reduced in 5-FU controls, there was 
no reduction in wet faecal output compared to healthy 
controls. However, in 5-FU treated rats administered 
HDR, faecal output was reduced by 41% in comparison 
to 5-FU controls. There were no significant effects on 
water intake and urine output between control and RE 
treatment groups (Table 2). Similarly, no significant 
effects on faecal moisture content were evident 
among all treatment groups, before or after 5-FU 
administration (data not shown).
Bodyweight change
A reduction in feed intake was consistent with de-
creased bodyweight after 5-FU administration (Figure 
2). Prior to inducing intestinal mucositis with 5-FU, RE 
had no significant effect on bodyweight. Treatment with 
5-FU resulted in a significant reduction in bodyweight 
compared to normal controls (P < 0.01). However, 
compared to 5-FU controls, HDR and LDR had no effect 
on mean bodyweight following 5-FU administration.
DAI score 
Administration of 5-FU significantly increased DAI 
scores in comparison to healthy controls (P < 0.01; 
Figure 3). Days 6 and 8 produced significantly greater 
DAI scores in 5-FU treated rats administered HDR 
and LDR, respectively, compared to 5-FU controls; 
otherwise, RE treatments had no significant effect on 
symptomatic disease activity.
Visceral gastrointestinal organ weights and lengths
Visceral and gastrointestinal organ weights were 
expressed as a proportion of bodyweight (Tables 3 
and 4). Reductions in relative thymus (by ≥ 35%; P 
< 0.001) and relative spleen weight (by ≥ 23%; P 
Table 1  Total daily food (g) and water (mL) intake, and 
faecal (g) and urine (mL) output for the trial period prior to 
the administration of 5-FU (days 1 to 5)
Water LDR HDR
Food intake (g)   51.0 ± 0.7 52.3 ± 2.0   53.8 ± 1.0
Water Intake (mL) 122.5 ± 7.3 129.4 ± 12.0 115.0 ± 7.1
Wet faecal output (g)     6.2 ± 0.3   6.8 ± 0.3     6.6 ± 0.4
Urine output (mL)   79.3 ± 5.6 79.8 ± 6.1   85.8 ± 5.0
Rats were gavaged daily with water, LDR or HDR (1 mL); data expressed 
as mean (g or mL) ± SEM. LDR: Low-dose RE; HDR: High-dose RE; RE: 
Rhubarb extract.
Table 2  Total daily food (g) and water (mL) intake, and 
faecal (g) and urine (mL) output for the trial period after the 









Food intake (g) 29.1 ± 0.6  11.5 ± 1.6e     7.8 ± 0.6   5.2 ± 1.4d
Water intake (mL) 75.0 ± 4.3 94.4 ± 7.7 107.2 ± 5.1 90.6 ± 12.9
Wet faecal output (g)   3.3 ± 0.2   2.9 ± 0.3     2.1 ± 0.3  1.7 ± 0.3c
Urine output (mL) 47.5 ± 4.7 64.5 ± 6.7   71.0 ± 2.1 70.6 ± 10.4
Rats were gavaged daily with water, LDR or HDR (1 mL) and received an 
intraperitoneal injection of either saline or 5-FU on day 5. cP < 0.05, dP < 0.01 
vs water + 5-FU; eP < 0.001 vs water + saline. All values are expressed as 
mean [% relative to bodyweight (× 10-2)] ± SEM. LDR: Low-dose RE; HDR: 
High-dose RE; RE: Rhubarb extract.
Figure 2  Daily change in starting bodyweight (%) from days 0 to 8 in rats 
gavaged with water, LDR or HDR and intraperitoneally injected with saline 
or 5-FU on Day 5. Data are expressed as mean ± SEM. Mean values of 5-FU 
controls and 5-FU + LDR and 5-FU + HDR were significantly different when vs 
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< 0.001) were apparent in all rats treated with 5-FU 
when compared to healthy controls (Table 3). In 5-FU 
treated rats, HDR and LDR had no significant effect on 
visceral organ weights compared to 5-FU controls. 
A significant decrease in the combined jejunum 
and ileum relative weight (by ≥ 10%; P < 0.01) was 
evident in all 5-FU treated rats (Table 4). However, this 
effect was not present in the duodenum. There was also 
no effect of HDR or LDR on relative duodenum weight 
and the combined relative weights of jejunum and 
ileum in 5-FU treated rats, compared to 5-FU controls. 
Administration of 5-FU had no effect on relative colon 
weight in comparison to healthy controls. However, 
when compared to 5-FU controls, administration of 
LDR to 5-FU treated rats significantly increased colon 
weight (29%; P < 0.01). Additionally, 5-FU significantly 
reduced the combined jejunum and ileum length in 
comparison to healthy controls (Table 5). However, 
this effect was not evident in the duodenum and colon. 
The administration of HDR and LDR to 5-FU treated 
rats had no effect on gastrointestinal organ lengths in 
comparison to 5-FU controls. 
Disease severity score
Healthy small intestinal sections achieved median 
disease severity scores of ≤ 2. Administration of 5-FU 
caused significant damage to intestinal structure in 
the jejunum, JI and ileum; achieving median (range) 
scores of 21 (18-30), 21 (14-27) and 22 (17-25), 
respectively, when assessed by semi­quantitative 
histological scores based on 11 parameters (Figure 
4). However, RE had no significant effect on intestinal 
structure, relative to 5-FU controls. 
MPO activity
Increased intestinal MPO activity is a common feature 
of chemotherapy­induced intestinal mucositis[31]. 
When compared to healthy controls, 5-FU resulted 
in increased MPO activity by 780% in the jejunum 
and 310% in the JI and ileum (Figure 5). RE had 
no significant effect on MPO activity within the 
jejunum and the JI in 5-FU treated rats. However, 
administration of LDR to 5-FU treated rats resulted in 
reduced MPO activity by 45% (P < 0.05) in the ileum, 
compared to 5-FU controls. 
Villus height, crypt depth and mucosal thickness 
The combined measurements of villus height and 
crypt depth provided an overall indication of mucosal 
Figure 3  Effects of rhubarb extract and 5-fluorouracil on disease activity 
scores on days 6 to 8 of the experimental period. Rats received a daily 
water, HDR or LDR gavage for an 8-d trial period and an intraperitoneal 
injection of 5-FU or saline on day 5. Disease activity scores were assigned on 
Days 6 to 8 based on overall condition, weight loss, stool consistency and rectal 
bleeding. bP < 0.01, eP < 0.001 vs water + saline; cP < 0.05 vs water + 5-FU. 
LDR: Low-dose RE; HDR: High-dose RE; RE: Rhubarb extract.
Table 3  Visceral organ weights of rats gavaged daily with 
water, low-dose or high-dose rhubarb extract (1 mL) during 
an 8-d trial period and administered with an intraperitoneal 
injection of saline or 5-fluorouracil on day 5








Thymus   14.6 ± 1.3    6.6 ± 0.5e   9.4 ± 0.6     9.5 ± 0.9
Heart   37.5 ± 0.8 39.0 ± 1.0   39.4 ± 0.8   39.1 ± 0.7
Lung   60.0 ± 2.2 63.0 ± 2.5   67.3 ± 4.7   71.9 ± 3.0
Liver 362.9 ± 6.5 362.7 ± 11.0 358.8 ± 7.2 339.7 ± 7.2
Spleen   20.3 ± 0.5  15.6 ± 0.3e   15.2 ± 0.4   14.6 ± 0.5
Kidneys   75.6 ± 5.3 86.5 ± 1.7   88.7 ± 1.1   89.4 ± 2.7
Caecum   39.7 ± 1.1 43.7 ± 2.4   49.2 ± 2.5   47.0 ± 2.1
Stomach   57.3 ± 2.6 55.3 ± 1.1   58.8 ± 0.9   61.9 ± 1.2
eP < 0.001 vs water + saline. All values are expressed as mean [% relative 
to bodyweight (× 10-2)] ± SEM. LDR: Low-dose RE; HDR: High-dose RE; 
RE: Rhubarb extract.
Table 4  Gastrointestinal organ weights of rats gavaged daily 
with water, low-dose and high-dose rhubarb extract (1 mL) 
during an 8-d rial period and administered an intraperitoneal 









Duodenum 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
Jejunum and ileum 2.1 ± 0.1  1.9 ± 0.0b 1.9 ± 0.2 1.9 ± 0.1
Colon 0.5 ± 0.0 0.5 ± 0.0  0.7 ± 0.0d 0.6 ± 0.0
bP < 0.01 vs water + saline; dP < 0.01 vs water + 5-FU. All values are 
expressed as mean (% relative to bodyweight) ± SEM. LDR: Low-dose RE; 
HDR: High-dose RE; RE: Rhubarb extract.
Table 5  Gastrointestinal organ lengths of rats gavaged daily 
with water, low-dose and high-dose rhubarb extract (1 mL) 
during an 8-d trial period and administered an intraperitoneal 









Duodenum   5.5 ± 0.2   4.8 ± 0.1   5.1 ± 0.2   4.8 ± 0.2
Jejunum and ileum 71.6 ± 2.3  64.8 ± 0.9a 62.9 ± 1.8 63.5 ± 1.7
Colon 11.1 ± 0.3 10.6 ± 0.4 11.2 ± 0.2 10.8 ± 0.4
aP < 0.05 vs water + saline. All values expressed as mean (cm) ± SEM. LDR: 
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thickness and thus, damage (Figure 6). Administration 
of 5-FU significantly decreased mucosal thickness 
by 29% in the jejunum, and 34% in both the JI and 
ileum when compared to healthy controls. RE had no 
significant effect on villus height and crypt depth in 
the jejunum, compared to 5-FU controls. This effect 
was mirrored in the JI, with the exception of crypt 
depth which was significantly greater (P < 0.05) in 
5-FU treated rats receiving HDR. More importantly, 
administration of LDR to 5-FU treated rats resulted in 
significantly greater ileal villus heights and crypt depths 
relative to 5-FU controls; significantly increasing overall 
ileal mucosal thickness by 19% (Figure 7). 
DISCUSSION
Intestinal mucositis remains a debilitating side­
effect of chemotherapy treatment. The current 
study utilised a rat model of intestinal mucositis to 
investigate the potential for aqueous RE to protect 
against damage to the intestinal mucosa and regulate 
water transport in the intestine. The water­soluble 
components of rhubarb appeared to target more distal 
regions of the alimentary tract, partially improving 
selected parameters of the ileum, such as mucosal 
thickness and MPO activity associated with the clinical 
manifestations of 5-FU-induced intestinal mucositis.
Administration of 5-FU significantly decreased feed 
intake and bodyweight as previously described[12,31,37]. 
A reduction in feed intake and bodyweight is observed 
in cancer patients due to nausea and pain associated 
with chemotherapy treatment[38,39]. Interestingly, in 
the current study, daily administration of HDR to 5-FU 
treated rats further reduced appetite but maintained 
bodyweight. It is therefore plausible that the caloric 
index of HDR may have been contributing to the 
reduced appetite, yet maintenance of bodyweight in 
the rats receiving high dose RE. 
In the current study, intraperitoneal administration 
of 5-FU caused significant damage to small intestinal 
structure, further impacting on intestinal weight and 
length. Previous studies of experimental intestinal 
mucositis have noted a correlation between small 
Figure 4  Histological damage assessed by semi-quantitative disease 
severity score of the jejunum, jejuno-ileum and ileum of rats. Data are 
expressed as median score (range). Mean values were significantly different 
vs water + 5-FU (fP < 0.001). JI: Jejuno-ileum; LDR: Low-dose RE; HDR: High-
dose RE; RE: Rhubarb extract.
Figure 5  Myeloperoxidase activity present in the jejunum, jejuno-ileum 
and ileum of rats gavaged with water, low-dose or high-dose rhubarb 
extract (1 mL) for an 8-d trial period. Rats received an intraperitoneal 
injection of saline or 5-FU on day 5. Data were expressed as mean [MPO Units 
(U)/g] ± SEM. Mean values were significantly different (fP < 0.001) vs water + 
5-FU. cP < 0.05 vs water + 5-FU. JI: Jejuno-ileum; LDR: Low-dose RE; HDR: 
high-dose RE; RE: Rhubarb extract.
Figure 6  Combination of villus height and crypt depth as a repre-
sentation of overall mucosal thickness in female Dark Agouti rats. Effects 
of RE and 5-FU on villus height and crypt depth in female Dark Agouti rats. 
Rats received a daily water, HDR or LDR gavage for an 8-d trial period and 
an intraperitoneal injection of 5-FU or saline on Day 5. Mean values were 
significantly different vs water + 5-FU (cP < 0.05, fP < 0.001). aP < 0.05, eP < 
0.001 vs water + saline. JI: Jejuno-ileum; LDR: Low-dose RE; HDR: High-dose 
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intestinal weight and mucosal integrity which was also 
demonstrated in the current study[13,31]. Jejunum and 
ileum weights were significantly decreased in 5-FU 
treated rats, accompanied by increased villus and 
crypt damage when compared to healthy controls. 
Enterocyte apoptosis in 5-FU treated rats was likely 
responsible for the reduced small intestinal weight. 
However, RE administered to 5-FU treated rats had no 
significant effect on intestinal weight, compared to 5-FU 
controls, which suggested that RE did not enhance cell 
regeneration after 5-FU toxicity. 
Administration of 5-FU may result in exposure of 
the submucosa to harsh luminal conditions[6]. As a 
compensatory mechanism, the muscularis externa 
contracts to reduce submucosal contact with the 
luminal environment in an attempt to prevent bacterial 
translocation. In the current study, the length of 
the total jejunum and ileum was reduced by 5-FU 
treatment, as described previously by Mashtoub et 
al[31]. However, consistent with previous studies, this 
effect was not present in the duodenum and colon as 
5-FU damage was less severe in these regions of the 
intestine[12,13,31].
In the current study, LDR treatment resulted in 
a significant increase in ileal villus height and crypt 
depth; possibly representing LDR promoted crypt 
cell regeneration and hence, increased migration of 
rejuvenated cells to the villus. Alternatively, LDR may 
have exerted an anti­oxidative effect, mediated by 
the water soluble polysaccharides of rhubarb which 
may have protected the intestinal mucosa against 
cell apoptosis; maintaining villus and crypt structure. 
A reduction in ileal MPO activity by LDR in 5-FU 
treated rats indicated a decrease in neutrophil activity 
which further supports the anti­oxidative and anti­
inflammatory properties of RE. These results are 
consistent with previous studies which have exploited 
plant polysaccharides for their anti­inflammatory 
and antioxidant properties[12,40,41]. Cheah et al[12,14] 
examined grape seed extract (GSE), a tannin rich by-
product of the wine and grape juice industries, in the 
setting of chemotherapy­induced intestinal mucositis. 
It was discovered that GSE could partially ameliorate 
small intestinal inflammation and mucosal damage 
caused by 5-FU cytotoxicity. Tannins, an active 
constituent of GSE and possibly RE, possess the ability 
to prevent the overproduction of ROS or decrease the 
production of pro-inflammatory cytokines such as IL-4 
and IFN-γ[12,17]. Further investigations are therefore 
required to understand the protective and anti­
inflammatory mechanism of action of RE in improving 
acute intestinal inflammation and damage to the 
mucosa. 
A significant improvement in ileal mucosal integrity 
and inflammation was observed in 5-FU rats treated 
with LDR, but not HDR. Limited RE studies have been 
Figure 7  A comparison of the histological structure of ileal sections in a healthy rat (A), after administration of 5-FU (B) and rats treated with LDR + 5-FU (C). 
Ileum sections of rats from the LDR + 5-FU treatment group (C) exhibited improved mucosal integrity as demonstrated by more defined villi and crypts in comparison 
to water + 5-FU controls (B). The black line on each diagram represents villus height in each section which was significantly shorter in 5-FU controls. Sections were 
stained with haematoxylin and eosin and mucosal thickness was analysed by quantitative measurements of villus height and crypt depth. Original photographs were 
captured at 4 × magnification. LDR: Low-dose rhubarb extract.
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conducted, therefore the low and high dose range 
of 20 mg/kg and 200 mg/kg were selected in the 
current study to determine the effects of RE across 
a broad dose range. The efficacy of RE in the current 
study may therefore have been dose­dependent. 
Prior to this study, the effects of RE on 5-FU-induced 
mucosal damage and inflammation were unknown 
and accordingly, the RE optimal concentration remains 
undefined. The present study suggested that the 
effectiveness of RE at varying concentrations may 
follow a normally distributed relationship. Potentially, 
at high concentrations (≥ 200 mg/kg BW), no 
significant effects may have been observed due to 
steric involution of bioactive binding sites. Further 
studies are therefore required to determine the optimal 
concentration to attain maximal mucosal protection. 
Chemotherapy recipients experiencing intestinal 
mucositis have altered membrane integrity and 
impaired water absorption and secretion[7]. Any 
molecule of a similar size or shape possesses the 
capability to attach to the pore vestibule and block 
the transport of water through AQP channels. 
Pharmacological blockers of aquaporin fluid fluxes 
are thought to occlude the pore vestibule and impede 
the bi­directional transport of water through the 
channel[42­44]. In the current study, RE present in the 
circulatory system may have targeted AQP 4 channels 
within enterocytes, resulting in a unidirectional blo­
ckade, and thereby decreased water secretion into 
the lumen of the small intestine. This hypothesised 
theory is further explained in Figure 1D. Wang et al[29] 
determined that AQP 4 knockout mice had significantly 
higher stool moisture content in comparison to wild­
type (P < 0.05). This suggested that stool consistency 
was dependent on the functionality of AQP 4 channels. 
This study also established that AQP 4 channels are 
scarce within the large intestine. Furthermore, within 
the large intestine, AQP 4 channels are only present on 
the initial section of the proximal colon[29]. Therefore, it 
is probable that fluid absorption and secretion across 
AQP 4 channels in the small intestine may have been 
partly responsible for the moisture content of the 
faeces in the current study. Further in vivo studies 
should identify the expression levels of AQP 4 and 
other aquaporins to determine morphological and 
potential functional changes after 5-FU exposure. Qin 
et al[18] demonstrated that aqueous RE improved stool 
consistency in mice with castor oil and magnesium 
sulphate-induced diarrhoea. Furthermore, aqueous 
RE caused constipation when administered to normal 
mice suggesting that RE may have been acting on AQP 
4 channels to alter water absorption in the intestine. 
Consequently, further studies are required to determine 
the moisture content of caecal fluid to confirm or 
refute the hypothesis that RE affects stool consistency. 
This would allow for comparison of water absorption 
and secretion in the small intestine, independent of the 
colon. A reduction in caecal moisture content would 
suggest that RE was preventing fluid secretion across 
small intestinal AQP 4 channels.
In summary, the present study demonstrated that 
the ancient herbal remedy RE in its aqueous form, 
at relatively low dose, offers partial protection to the 
distal intestinal mucosa against tissue damage and 
inflammation associated with 5-FU-induced intestinal 
mucositis. Further studies are warranted to identify the 
anti-inflammatory and antioxidant properties of RE via 
examination of inflammatory cytokines in blood and 
tissue. This provides preliminary information regarding 
the potential use of RE as an adjunct to chemotherapy 
to improve particular histological manifestations 
of intestinal mucositis. Moreover, the reduced ileal 
inflammation and improved mucosal thickness 
suggests further therapeutic potential for other 
gastrointestinal inflammatory disorders that ultimately 
affect the more distal regions of the alimentary tract. 
However, the potential drug-drug interactions of 
RE and chemotherapy drugs, such as 5-FU should 
be thoroughly investigated as recent studies have 
highlighted concern over such interactions[45]. Future 
research should also focus on analysing moisture 
content of caecal fluid to determine whether RE acts as 
a unidirectional blocker of AQP 4 channels in the small 
intestine. Finally, further investigation into the active 
constituents of RE would be beneficial to improve our 
understanding of its potential utility in bowel disease 
and its associated mechanism of action. 
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compound so that it can be extracted and further examined for clinical efficacy.
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concentration for comparison. Aquaporins (AQPs) are integral membrane 
proteins responsible for the regulation of water transport across a membrane 
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